Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 79,390 shares at $7.80 ($613K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Open-market sale of $613k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.80 | 24,479 | $191K | 31.2% |
| 2 | $7.80 | 24,479 | $191K | 31.2% |
| 3 | $7.48 | 7,521 | $56K | 9.2% |
| 4 | $7.48 | 7,521 | $56K | 9.2% |
| 5 | $7.68 | 7,695 | $59K | 9.6% |
| 6 | $7.68 | 7,695 |
| $59K |
| 9.6% |
| Total | $7.72 avg | 79,390 | $613K | 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |